Initiator Pharma A/S (STO:INIT)
2.500
-0.060 (-2.34%)
Nov 20, 2026, 5:25 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 171.13 million as of November 20, 2026. It is the 37,701st most valuable company in the world and the 524th biggest in Sweden. Its market cap has decreased by 8.76% in one year.
Market Cap
171.13M
Enterprise Value
167.75M
Revenue
n/a
Global Rank
Country Rank
#524 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 171.13M, an increase of 239.77%. That is a compound annual growth rate of 13.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 171.13M | -15.54% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intervacc AB | 224.94M |
| Mendus AB | 217.29M |
| Xbrane Biopharma AB | 213.27M |
| Elicera Therapeutics AB | 164.51M |
| Abera Bioscience AB | 140.62M |
| Diamyd Medical AB | 138.25M |
| BioInvent International AB | 137.53M |
| Simris Group AB (PUBL) | 137.49M |